Anstey, K. (2008). Cognitive aging and functional biomarkers. In S. Hofer and D. Alwin Eds. Handbook of cognitive aging: interdisciplinary perspectives Thousand Oaks, California: Sage;327 .
Elias, P., Elias, MF., D’Agostino, RB., et al. (2005). Serum cholesterol and cognitive performance in the Framingham Heart Study. J Biobehavioral Medical; 67(1): 24-30.
Kline, RB. (2005). Principles and practice of structural equation modeling; New York: Guilford Press
Lindeboom, J., Weinstein, H. (2004). Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer’s disease, and vascular cognitive impairment. European Journal of Pharmacology; 490: 83–6.
Marshall, A., Rentz, M., Frey, T., Locascio, J., Johnson, A., Sperling, A. (2011).Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer’s disease. Alzheimer’s & Dementia, 7, 300 - 308.
Mitchell, J. & Shiri-Feshki, M. (2009). Rate of progression of mild cognitive impairment to dementia meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica, 119 (4), 252–265.
Okusaga, Ο., Stewart, ΜCW., Butcher, I., et al. (2012). Smoking, hypercholesterolaemia and hypertension as risk factors for cognitive impairment in older adults. Age Ageing; 42(3): 306-11.
Ready, E., Ott, R., Grace, J., & Cahn-Weiner, A. (2003). Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease. American Journal of Geriatric Psychiatry, 11(2), 222–228.
Spiro, A., Brady, C. (2008). Integrating health into cognitive aging research and theory. In S. Hofer and D. Alwin Eds. Handbook of cognitive aging: interdisciplinary perspectives Thousand Oaks, California: Sage: 260-83.
Zheng, D., Sun, H., Dong, X., Liu, B., Xu, Y., Chen, S., Song, L., Zhang, H., Wang, X. (2014). Executive dysfunction and gray matter atrophy in amnestic mild cognitive impairment. Neurobiology of Aging, 35, 548 - 555.